Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
SAN FRANCISCO and WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company…
Pharmaceuticals, Biotechnology and Life Sciences
SAN FRANCISCO and WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company…
Cytek Wuxi Facility Cytek’s new 50,000-square-foot facility in Wuxi, China increases the company’s manufacturing capacity to meet the growing worldwide…
Oslo, 7 March 2024: Langøya Invest AS, a closely related party of Ketil Fjerdingen, a board member and primary insider…
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) — SkinCure Oncology, the world leader in providing a comprehensive model for…
Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business Update Advanced Viaskin™ Peanut clinical…
NEW YORK and and WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus”), a clinical-stage biotechnology…
BOSTON, March 07, 2024 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next…
DURHAM, N.C., March 07, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated contract…
Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE…
MOUNTAIN VIEW, Calif., March 07, 2024 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and…